Elypta: Funding, Investors & Team (Oct 2026)
Elypta is fostering a digestion put together fluid biopsy stage based with respect to another IVD research facility measure unit and man-made consciousness calculations prepared by their clinical data set. Elypta gladly supports the clinical preliminary series AURORAX to explore applications in their lead sign renal cell carcinoma from observation of repeat to checking treatment reaction. They additionally investigate a few different signs to figure out the maximum capacity for Elypta's foundation.
Elypta has raised $21.0M across 1 funding round on record, the most recent a Series A of $21.0M announced in Jun 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Elypta Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Elypta Funding Rounds
Elypta Founders and Leadership Team
No contact details are on record for this team yet.
Elypta Funding Compared to Other Biotechnology Startups
Elypta's latest round of $21.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Elypta in Biotechnology and Stockholm
Companies Similar to Elypta
Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every…
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
Elypta Funding FAQs
What does Elypta do?
Elypta is fostering a digestion put together fluid biopsy stage based with respect to another IVD research facility measure unit and man-made consciousness calculations prepared by their clinical data set. Elypta gladly supports the clinical preliminary series AURORAX to explore applications in their lead sign renal cell carcinoma from observation of repeat to checking treatment reaction. They additionally investigate a few different signs to figure out the maximum capacity for Elypta's foundation.
How much funding has Elypta raised?
Elypta has raised $21.0M across 1 round on record. The most recent is a Series A of $21.0M announced in Jun 2022.
When did Elypta last raise funding?
Elypta's most recent funding round on record is a Series A of $21.0M, announced in Jun 2022.
Who founded Elypta?
FundedIQ lists Francesco Gatto (Founder) at Elypta.
Where is Elypta headquartered?
Elypta is based in Stockholm, Stockholms Lan, Sweden.
How many employees does Elypta have?
Elypta is in the 11-50 employee band.
How does Elypta's funding compare to other Biotechnology startups?
Elypta's latest round of $21.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Elypta Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Elypta is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.